Valuation : SI-BONE, Inc.

Market Cap 852M 734M 689M 629M 1.18B 81.11B 1.19B 8.17B 3.18B 41.13B 3.2B 3.13B 136B P/E 2026 *
-47.4x
P/E 2027 * -56.4x
Enterprise Value 859M 739M 694M 634M 1.19B 81.72B 1.2B 8.23B 3.2B 41.44B 3.22B 3.15B 137B EV / Sales 2026 *
3.7x
EV / Sales 2027 * 3.18x
Free-Float
96.73%
Yield 2026 *
-
Yield 2027 * -
1 week-1.80%
1 month+6.49%
3 months+34.43%
6 months+25.19%
Current year-3.53%
1 week 16.4
Extreme 16.4
16.9
1 month 14.8
Extreme 14.8
17.1
3 years 9.85
Extreme 9.85
21.4
5 years 9.85
Extreme 9.85
26.8
Manager TitleAgeSince
Chief Executive Officer 59 2021-04-19
Director of Finance/CFO 46 2021-04-18
Chief Tech/Sci/R&D Officer 60 2024-11-30
Director TitleAgeSince
Chairman 71 2008-03-17
Director/Board Member 72 2012-12-31
Director/Board Member 56 2008-03-17
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.80%+14.69%-21.90% 852M
+0.44%-0.20%+18.51%+22.16% 12.73B
+0.68%+0.12%+17.03%+28.87% 6.93B
+0.72%-6.25%+45.23%+27.97% 6.26B
+0.80%+1.60% - - 5.69B
-1.20%-6.96%-13.79%+45.61% 5.08B
-1.18%+2.00%-30.61%-23.99% 3.85B
-0.95%+5.31%+44.79%-19.99% 2.06B
+1.50%+12.73%-1.61%+135.91% 1.78B
+2.08%+2.57%+53.29%-13.08% 1.6B
Average +0.32%+0.66%+16.39%+20.17% 5.11B
Weighted average by Cap. +0.28%-0.69%+15.46%+23.28%

Financials

2026 *2027 *
Net sales 232M 200M 188M 171M 322M 22.09B 324M 2.22B 865M 11.2B 872M 853M 37.08B 268M 231M 217M 198M 372M 25.54B 375M 2.57B 1B 12.95B 1.01B 986M 42.89B
Net income -17.76M -15.29M -14.36M -13.11M -24.62M -1.69B -24.8M -170M -66.2M -857M -66.69M -65.24M -2.84B -15.42M -13.28M -12.47M -11.38M -21.38M -1.47B -21.53M -148M -57.48M -744M -57.9M -56.64M -2.46B
Net Debt 6.44M 5.54M 5.2M 4.75M 8.92M 612M 8.99M 61.65M 23.99M 310M 24.16M 23.64M 1.03B 715K 615K 578K 527K 991K 67.98M 998K 6.84M 2.66M 34.47M 2.68M 2.62M 114M
Logo SI-BONE, Inc.
SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.
Employees
-
Date Price Change
26-09-01 16.40 0.00%
26-08-31 €16.40 -1.80%
26-08-28 €16.70 +0.60%
26-08-27 €16.60 -0.60%
26-08-26 €16.70 0.00%
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
19.02USD
Average target price
25.00USD
Spread / Average Target
+31.44%

Quarterly revenue - Rate of surprise